期刊文献+

双源CT冠状动脉造影对冠心病患者冠状动脉狭窄的诊断价值 被引量:24

Diagnostic Value of Dual-source CT Coronary Angiography in Coronary Artery Stenosis of Patients with Coronary Heart Disease
下载PDF
导出
摘要 目的探讨双源CT冠状动脉造影(DSCTA)对冠心病患者冠状动脉狭窄的诊断价值。方法选取2017年9月-2018年9月间收治的拟诊为冠心病的患者120例作为研究对象,所有患者均予以DSCTA、冠状动脉造影(CAG)和冠状动脉血管内超声(IVUS)检查。以CAG为金标准,评估DSCTA诊断冠脉狭窄的效能、狭窄程度准确率;以IVUS检查为金标准,评估DSCTA诊断斑块性质的效能。结果①DSCTA诊断冠脉狭窄的灵敏度为93.75%、特异度97.78%、准确率96.67、阳性预测值94.17%、阴性预测值97.62%;②DSCTA准确诊断无狭窄冠脉节段1147段、准确率97.62%,DSCTA准确诊断轻度冠脉狭窄节段124段、准确率84.93%(124/146),准确诊断中度冠脉狭窄节段106段、准确率84.80%(106/125),准确诊断重度冠脉狭窄节段163段、准确率93.14%(163/175);③IVUS共检测出394个粥样硬化斑块,DSCTA准确诊断软斑块105个、准确率82.68%(105/127),DSCTA准确诊断纤维型斑块126个、准确率89.36%(126/141),DSCTA准确诊断钙化斑块31个、准确率81.58%(31/38),DSCTA准确诊断混合斑块74个、准确率84.09%(74/88)。结论 DSCTA安全无创,在冠心病的诊断、狭窄程度评估、粥样硬化斑块的定性方面均具有较高的诊断效能。 Objective To evaluate the diagnostic value of dual-source computed tomography coronary angiography(DSCTA)in coronary artery stenosis of patients with coronary heart disease.Methods A total of 120 patients with coronary heart disease who admitted between September 2017 and September 2018 were selected for the study.All patients were given DSCTA,coronary angiography(CAG)and coronary intravascular ultrasound(IVUS).CAG was used as the gold standard to evaluate the efficacy and accuracy rate of stenosis of DSCTA in the diagnosis of coronary stenosis.IVUS examination was taken as the gold standard to evaluate the efficacy of DSCTA in diagnosing plaque properties.Results The sensitivity,specificity,accuracy rate,positive predictive value and negative predictive value of DSCTA in the diagnosis of coronary stenosis were 93.75%,97.78%,96.67,94.17%and 97.62%.1147 segments without coronary stenosis were accurately diagnosed by DSCTA and the accuracy rate was 97.62%,and 124 segments with mild coronary stenosis were diagnosed by DSCTA accurately and the accuracy rate was 84.93%(124/146),and 106 segments with moderate coronary stenosis were diagnosed and the accurate rate was 84.80%(106/125),and 163 segments with severe coronary stenosis were diagnosed and the accurate rate was 93.14%(163/175).A total of 394 atherosclerotic plaques were detected by IVUS,and 105 soft plaques were diagnosed DSCTA accurately and the accuracy rate was 82.68%(105/127),and 126 fibrous plaques were accurately diagnosed DSCTA and the accuracy rate was 89.36%(126/141),and 31 calcified plaques were diagnosed accurately by DSCTA and the accuracy rate was 81.58%(31/38),and 74 mixed plaques were diagnosed by DSCTA and the accuracy rate was 84.09%(74/88).Conclusion DSCTA is safe and non-invasive,and has high efficacy in diagnosing coronary stenosis,the degree of stenosis,and the diagnosis of atherosclerotic plaque in patients with coronary heart disease.
作者 张梅 殷云志 周炜 代芳霞 ZHANG Mei;YIN Yun-zhi;ZHOU Wei(Department of Cardiovascular Medicine,Wuhan Central Hospital Affiliated to Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430000,Hubei Province,China)
出处 《中国CT和MRI杂志》 2019年第5期68-71,共4页 Chinese Journal of CT and MRI
关键词 冠心病 冠状动脉狭窄 双源电子计算机断层扫描冠状动脉造影 诊断 Coronary Heart Disease Coronary Artery Stenosis Dual-source Computed Tomography Coronary Angiography Diagnosis
  • 相关文献

参考文献15

二级参考文献125

  • 1钱丽萍.心脏性猝死的病因与诱因分析[J].浙江中医药大学学报,2011,35(2):170-171. 被引量:9
  • 2蔡军,张龙江,卢光明,黄伟,周长圣,赵艳娥,孙志远,梁泉.双源CT冠状动脉成像检查异常冠状动脉起源的意义[J].医学研究生学报,2011,24(8):835-839. 被引量:7
  • 3Bhatt DL, Bertrand ME, Berger BP, et al. Meta-anaiysis of randomized and registries comparison of ticlopidine with clopidogrel after stenting [ J ]. J Am Coll Cardiol, 2002,39(1) :9-14.
  • 4Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST- segment elevation [ J ].N Engl J Med, 2001,345 (7) : 494-502.
  • 5Sabatine MS, Cannon CP, GibsonCM, etal. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST- segment elevation[ J] .N Engl J Med, 2005,352(12) : 1179-1189.
  • 6Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myo- cardial infarction : randomised placebo-controlled trial [ J ]. Lancet, 2005,366 (9497) : 1607-1621.
  • 7Kereiakes D J, Gurbel PA. Peri-pro- cedural platelet function and platelet inhibition in percutaneous coronary intervention[J] .JACC Cardiovasc In- terv, 2008,1(2):111-121.
  • 8Soft F, Marcucci R, Gori AM, et al. Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis [ J ]. Thromb Haemost, 2010,103 (4) : 841-848.
  • 9Mehta SR, Tanguay JF, Eikelboom Jw, et al. Double-dose versus standard-dose clopidogrel and high- dose versus low-dose aspirin in indi- viduals undergoing pereutaneous coronary intervention for acute coronary syndromes ( CURRENT- OASIS 7 ): a randomized factorial trial [ J ]. Lancet, 2010, 376 ( 1 ) : 1233-1243.
  • 10Mega JL, Close S, Wiviott SD, et al. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopi- dogrel and prasugrel in the TRITON- TIMI 38 trial: a pharmacogenetic analysis [ J ]. Lancet, 2010, 376 (9749) : 1312-1319.

共引文献239

同被引文献238

引证文献24

二级引证文献143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部